NIH-funded research R21 grant

Understanding how certain B cells affect skin inflammation

Official title: The role of CXCL10 expressing B cells in skin inflammation

Funded at Thomas Jefferson University · NIH-11109473 · Data updated 2026-11-12

This study is looking at how certain immune cells called regulatory B cells help control skin inflammation in conditions like psoriasis and allergic contact dermatitis, and it aims to find new ways to treat these skin issues by understanding how these cells interact with other immune cells.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJune 6, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$234,000
NIH project number5R21AI182763-02
Project IDNIH-11109473 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from inflammatory skin diseases such as psoriasis or allergic contact dermatitis.

Less likely to help

Patients with non-inflammatory skin conditions or those not affected by skin diseases may not benefit from this research.

What this research studies

This research investigates the role of regulatory B cells in managing skin inflammation, particularly in conditions like psoriasis and allergic contact dermatitis. It focuses on how these B cells produce a molecule called CXCL10, which may influence the behavior of T cells involved in inflammation. By using a mouse model, the researchers aim to understand the mechanisms by which B cells interact with T cells to either suppress or enhance inflammatory responses. This could lead to new strategies for treating inflammatory skin diseases.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better control skin inflammation and improve the quality of life for patients with inflammatory skin conditions.

How similar studies have gone: Previous research has shown promising results in understanding the role of B cells in inflammation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Debes, Gudrun Philomena — Thomas Jefferson University
  • Study coordinator: Debes, Gudrun Philomena

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.